PVI
BCLI

Pura Vida Investments’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Pura Vida Investments’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,493
Closed -$321K – 242
2021
Q3 		$321K Buy
+6,493
New +$342K 0.01% 263

Other funds holding BCLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AHB
Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pura Vida Investments's BCLI Position: Q4 2021 in Review

Pura Vida Investments sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q4 2021, closing a stake of 7,122 shares — an estimated $353K sold.

Pura Vida Investments first reported a position in BCLI in Q3 2021 and held it in 1 quarter. The position peaked at $353K in Q3 2021. 43 funds tracked by Wall St. Rank hold BCLI as of Q4 2021.

  • Pura Vida Investments reported no remaining BRAINSTORM CELL THERAPUTC position as of Q4 2021 after selling out during the quarter.
  • Pura Vida Investments sold 7,122 BRAINSTORM CELL THERAPUTC shares in Q4 2021, an estimated $353K.
  • Pura Vida Investments first reported a position in BRAINSTORM CELL THERAPUTC in Q3 2021 and held it in 1 quarter.
  • Pura Vida Investments's BRAINSTORM CELL THERAPUTC position peaked at $353K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.